中孚實業(600595.SH):以信託貸款方式向中國華融申請2.47億元授信額度
格隆匯3月15日丨中孚實業(600595.SH)公佈,公司第十屆董事第十一次會議審議通過了《關於公司以子公司部分資產抵押申請授信額度的議案》,同意公司以信託貸款方式向中國華融資產管理股份有限公司申請2.47億元授信額度,期限為24個月,並設置寬限期12個月,資金用途為支付四川豫恒實業有限公司(已更名為“四川中孚科技發展有限公司”)股權收購餘款,此筆授信公司擬以子公司河南中孚電力有限公司部分機器設備(該部分機器設備賬面價值為46,819萬元)為抵押,並以子公司四川中孚科技發展有限公司持有的廣元中孚高精鋁材有限公司51.51%的股權提供質押擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.